TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31090551

Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation program (in-hospital high-intensity endurance and strength training, high-protein nutrition and supplements, smoking cessation, psychological support)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 50
Study: 28071141

Group type: EXPERIMENTAL
Intervention: CHoBI7 intervention (1-week handwashing with soap and water treatment)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 344
Study: 26842115

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 177

Group type: COMPARATOR
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Early pacing-induced DYS
Number of subjects: 177
Study: 24158335

Group type: EXPERIMENTAL
Intervention: Mandibular two-implant overdentures (IOD)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Conventional complete dentures (CD)
Number of subjects: 255
Study: 21130593

Group type: EXPERIMENTAL
Intervention: High dose thiamine therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 60
Study: 18766474

Group type: EXPERIMENTAL
Intervention: Physician group (PG)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Nurse group (NG)
Number of subjects: 264
Study: 17325297

Group type: EXPERIMENTAL
Intervention: Web-based education program on systems-based practice competencies
Number of subjects: 693

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 693
Study: 15346110

Group type: EXPERIMENTAL
Intervention: Clinical examination
Number of subjects: 50

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 50
Study: 11588903

Group type: COMPARATOR
Intervention: 0 g of ground flaxseed
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 5 g of ground flaxseed
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 10 g of ground flaxseed
Number of subjects: 28
Study: 9519318

Group type: EXPERIMENTAL
Intervention: Imipramine 50 mg daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8080597

Group type: EXPERIMENTAL
Intervention: Alcohol administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2762082

Group type: EXPERIMENTAL
Intervention: Visual components of a televised program
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of visual and auditory input
Number of subjects: 80

Group type: COMPARATOR
Intervention: Auditory components of a televised program
Number of subjects: 80
Study: 406102

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31400049

Group type: EXPERIMENTAL
Intervention: Prophylactic valgancyclovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preemptive valgancyclovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose valacyclovir
Number of subjects: 0
Study: 29202456

Group type: EXPERIMENTAL
Intervention: Pimozide (neuroleptic)
Number of subjects: 0
Study: 25601966

Group type: EXPERIMENTAL
Intervention: Capecitabine 800 mg/m² twice daily throughout the 21-day cycle (Ccont)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Capecitabine 1,250 mg/m² twice daily for 2 weeks on and 1 week off (Cint)
Number of subjects: 195
Study: 24009092

Group type: EXPERIMENTAL
Intervention: Low-dose chest CT (LDCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose chest CT (LDCT) with PSFR cutoffs
Number of subjects: 0
Study: 21269278

Group type: EXPERIMENTAL
Intervention: Eszopiclone 3 mg
Number of subjects: 17
Study: 19922995

Group type: EXPERIMENTAL
Intervention: Losartan 150 mg daily
Number of subjects: 3846

Group type: COMPARATOR
Intervention: Losartan 50 mg daily
Number of subjects: 3846
Study: 16630454

Group type: EXPERIMENTAL
Intervention: rhBNP (0.15 microg/kg bolus intravenous injection followed by 0.0075 microg.kg(‐1).min(‐1) for 24 hours, n = 105)
Number of subjects: 209

Group type: COMPARATOR
Intervention: NIT (starting at 10 microg/min and increasing 5 microg/min each time till clinical effective dose for 24 hours, n = 104)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Both rhBNP and NIT
Number of subjects: 209
Study: 14652125

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (Group A)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No epidural anesthesia (Group B)
Number of subjects: 105
Study: 10778764

Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 103
Study: 9051872

Group type: EXPERIMENTAL
Intervention: Flosulide (20 mg twice a day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Naproxen (500 mg twice a day)
Number of subjects: 19
Study: 8404438

Group type: EXPERIMENTAL
Intervention: Diet with 19% of energy from sucrose
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diet with < 3% of energy from sucrose (starch diet)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 12
Study: 3538843

Group type: EXPERIMENTAL
Intervention: 50 g protein
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 g glucose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 g protein + 50 g glucose
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (fasting baseline)
Number of subjects: 8
Study: 31925833

Group type: EXPERIMENTAL
Intervention: Intervention: accelerometer paired with financial incentives and health engagement questions
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control
Number of subjects: 127

Group type: COMPARATOR
Intervention: Accelerometer
Number of subjects: 127
Study: 29718297

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer (FET)
Number of subjects: 3665

Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 3665
Study: 26957232

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (LAH) applied on day 3 frozen embryos before frozen embryo transfer (FET)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Control group (no treatment applied on frozen embryo before transfer)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (LAH)
Number of subjects: 413
Study: 24632110

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for SAD, 16 weekly sessions of individual CBT.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expressive suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reappraisal success increases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reappraisal success increases pre‐to‐post‐CBT
Number of subjects: 0
Study: 22716131

Group type: EXPERIMENTAL
Intervention: Voluntary counseling and testing, community mobilization and post-test support services intervention
Number of subjects: 0
Study: 19781591

Group type: EXPERIMENTAL
Intervention: CPP-ACP treatment (Tooth Mousse, GC Corp.) for 60 min x 7 days with 2-step self-etching primer adhesive (Clearfil SE Bond, Kuraray Medical)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CPP-ACP treatment (Tooth Mousse, GC Corp.) for 60 min x 7 days with 'all-in-one' adhesive (G-Bond, GC Corp.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (untreated dentine) with 2-step self-etching primer adhesive (Clearfil SE Bond, Kuraray Medical)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (untreated dentine) with 'all-in-one' adhesive (G-Bond, GC Corp.)
Number of subjects: 34
Study: 18441323

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily (S80)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg and simvastatin 10 mg daily (E10/S10)
Number of subjects: 39
Study: 11925401

Group type: EXPERIMENTAL
Intervention: 4% icodextrin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ringer's lactated saline (RLS)
Number of subjects: 62
Study: 10089069

Group type: EXPERIMENTAL
Intervention: Regimen A (THP‐COP) containing pirarubicin (30 mg/m2; day 1)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Regimen B (modified CHOP) containing doxorubicin (30 mg/m2; day 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Regimen C (THP‐COPE) including etoposide (80 mg/m2; day 1) in addition to regimen A
Number of subjects: 37
Study: 7744384

Group type: EXPERIMENTAL
Intervention: Acetaminophen oral drop (1000 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acetaminophen tablet (1000 mg)
Number of subjects: 8
Study: 2721259

Group type: EXPERIMENTAL
Intervention: terbutaline, 15 mg daily for five weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 30380038

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis with sulfadoxine‐pyrimethamine plus artesunate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28734154

Group type: EXPERIMENTAL
Intervention: Brief motivational smoking cessation intervention emphasizing reduced drinking
Number of subjects: 317

Group type: COMPARATOR
Intervention: Standard smoking cessation intervention (brief informational)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Both groups (motivational and informational)
Number of subjects: 317
Study: 24949564

Group type: EXPERIMENTAL
Intervention: Varenicline (VAR; 1 mg twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX; 25 mg once daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Varenicline plus Naltrexone (VAR + NTX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23507293

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) - three manualized sessions including one physical activity exposure session
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care from general practitioner
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 40
Study: 22007505

Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 109

Group type: COMPARATOR
Intervention: Routine discharge guidance
Number of subjects: 109
Study: 19351942

Group type: EXPERIMENTAL
Intervention: Usual care plus aerobic exercise training (n = 1172)
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care alone (n = 1159)
Number of subjects: 2331
Study: 16428996

Group type: EXPERIMENTAL
Intervention: Nonsterile tape
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Hub-Guard
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: StatLock
Number of subjects: 3
Study: 15596721

Group type: EXPERIMENTAL
Intervention: Midazolam injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 0
Study: 11387299

Group type: EXPERIMENTAL
Intervention: 25 microg gestodene
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 50 microg gestodene
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 23
Study: 9004057

Group type: EXPERIMENTAL
Intervention: Clozapine 300 mg or 600 mg
Number of subjects: 30
Study: 7680833

Group type: EXPERIMENTAL
Intervention: Cortisol infusion (2 micrograms.kg‐1.min‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study: 3100145

Group type: EXPERIMENTAL
Intervention: Intravenous isosorbide dinitrate (ISDN)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nitroglycerine (NTG)
Number of subjects: 45
Study: 30732125

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg/d) + chemotherapy
Number of subjects: 175

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Apatinib + chemotherapy
Number of subjects: 175
Study: 28532861

Group type: EXPERIMENTAL
Intervention: Open Communication (OpenComm)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: AskShareKnow
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 200
Study: 25156125

Group type: EXPERIMENTAL
Intervention: Subgingival glycine powder air polishing (GPAP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Subgingival scaling with hand instruments (SRP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Subgingival ultrasonic debridement (UD)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No subgingival treatment (NT)
Number of subjects: 25
Study: 23558080

Group type: EXPERIMENTAL
Intervention: WalkAide (WA) foot-drop stimulator
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Conventional ankle-foot orthosis (AFO)
Number of subjects: 93

Group type: COMPARATOR
Intervention: AFO
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both WA and AFO
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: WalkAide (WA)
Number of subjects: 93
Study: 22420439

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal reflux
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Esophageal reflux
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of nasopharyngeal reflux incidence
Number of subjects: 20
Study: 19346194

Group type: EXPERIMENTAL
Intervention: HT treatment group (2 mg 17beta‐estradiol + 1 mg norethisterone acetate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 40
Study: 16940448

Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg thrice daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15234826

Group type: EXPERIMENTAL
Intervention: Thyroid-stimulating hormone (TSH) testing
Number of subjects: 883
Study: 11727184

Group type: EXPERIMENTAL
Intervention: Chemo- and chemoimmunotherapy
Number of subjects: 3696

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 3696
Study: 18476190

Group type: EXPERIMENTAL
Intervention: Grepafloxacin (400 mg, single oral dose)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Cefixime (400 mg, single oral dose)
Number of subjects: 380
Study: 8502095

Group type: EXPERIMENTAL
Intervention: Electrocautery excision
Number of subjects: 28

Group type: COMPARATOR
Intervention: Dissection/snare followed by point coagulation
Number of subjects: 28
Study: 3581488

Group type: EXPERIMENTAL
Intervention: Posterior rhinomanometry
Number of subjects: 15

Group type: COMPARATOR
Intervention: Anterior rhinomanometry
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Total nasal resistance derived from posterior rhinomanometry
Number of subjects: 15
Study: 27473218

Group type: EXPERIMENTAL
Intervention: Normal OGTT response
Number of subjects: 35

Group type: COMPARATOR
Intervention: Abnormal OGTT response
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Prediabetic patients
Number of subjects: 35
Study: 27634669

Group type: EXPERIMENTAL
Intervention: CASA intervention (nurse-led symptom management and social worker support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24621826

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST36) and Sanyinjiao (SP6)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Etomidate anesthesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham acupuncture (non-acupoints)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 80
Study: 21840169

Group type: EXPERIMENTAL
Intervention: Video-enhanced voice therapy using portable digital media players with clinician and self-videos
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard of care voice therapy with written homework descriptions
Number of subjects: 13
Study: 20685923

Group type: EXPERIMENTAL
Intervention: Colored cue associated with an executed movement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colored cue associated with an observed movement
Number of subjects: 0
Study: 17846098

Group type: EXPERIMENTAL
Intervention: Ambient odor during task performance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relevant control groups
Number of subjects: 0
Study: 16455288

Group type: EXPERIMENTAL
Intervention: Oral Balance gel delivered by slow release via a novel intra‐oral device
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral Balance gel in bolus form
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral Balance gel (both forms)
Number of subjects: 22
Study: 14581273

Group type: EXPERIMENTAL
Intervention: TACE-PAI
Number of subjects: 108

Group type: COMPARATOR
Intervention: PAI
Number of subjects: 108
Study: 10971552

Group type: EXPERIMENTAL
Intervention: Hyperventilation (short-term)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Baseline ventilation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 99mTc-HMPAO during hyperventilation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Focal perfusion abnormalities
Number of subjects: 17
Study: 8855797

Group type: EXPERIMENTAL
Intervention: Flutamide, testolactone, reduced hydrocortisone dose (from 12.9 to 7.9 mg/m2 day), and fludrocortisone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrocortisone and fludrocortisone treatment
Number of subjects: 12
Study: 1613128

Group type: EXPERIMENTAL
Intervention: verapamil (120 mg every 8 hr)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: diltiazem (90 mg every 8 hr)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: labetalol (200 mg every 12 hr)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo (every 12 hr)
Number of subjects: 12
Study: 6512783

Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Other delivery routes (not specified)
Number of subjects: 40
Study: 31246522

Group type: EXPERIMENTAL
Intervention: Clofarabine and cytarabine (Clo+AraC, n = 129)
Number of subjects: 285

Group type: COMPARATOR
Intervention: High-dose cytarabine, daunorubicin, and etoposide (HD-ADE, n = 133)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Clofarabine and cytarabine (Clo+AraC)
Number of subjects: 285

Group type: COMPARATOR
Intervention: High-dose cytarabine, daunorubicin, and etoposide (HD-ADE)
Number of subjects: 285
Study: 29693366

Group type: EXPERIMENTAL
Intervention: Vision screening accompanied by eye exams and free eyeglasses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced vision screening alone
Number of subjects: 0
Study: 26703245

Group type: EXPERIMENTAL
Intervention: Final PCWP ≥ 20 mmHg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Higher final right atrial pressure
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Final CI
Number of subjects: 151
Study: 25010538

Group type: EXPERIMENTAL
Intervention: HAL gait training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional gait training
Number of subjects: 22
Study: 23514679

Group type: EXPERIMENTAL
Intervention: Self-etching primer
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional etch (37% phosphoric acid etchant)
Number of subjects: 180
Study: 20133929

Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg for 7 days
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 17394656

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 1 month
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 6 months
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 12 months
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 2 years
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 4 years
Number of subjects: 1367

Group type: EXPERIMENTAL
Intervention: Hypothetical preventive drug treatment with heart attack postponement of 8 years
Number of subjects: 1367
Study: 16344321

Group type: EXPERIMENTAL
Intervention: Sx + Ax (surgery plus axillary clearance) followed by tamoxifen for 5 years
Number of subjects: 473

Group type: COMPARATOR
Intervention: Sx (surgery without axillary clearance) followed by tamoxifen for 5 years
Number of subjects: 473
Study: 12815686

Group type: EXPERIMENTAL
Intervention: Magnetization transfer (MT) pulses applied with optimized modulation of flip angle according to phase-encoded view's distance to the center of k-space.
Number of subjects: 11
Study: 10469936

Group type: EXPERIMENTAL
Intervention: Botulinum A toxin injections into the gastrocnemius muscle
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline vehicle injections into the gastrocnemius muscle
Number of subjects: 20
Study: 8596827

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 107
Study: 1942019

Group type: EXPERIMENTAL
Intervention: Educational program for skin cancer detection and prevention
Number of subjects: 0
Study: 6133072

Group type: EXPERIMENTAL
Intervention: Chlorhexidine added to urine drainage bags
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no chlorhexidine)
Number of subjects: 0
Study: 30679414

Group type: EXPERIMENTAL
Intervention: ALEM plus tacrolimus (TAC) monotherapy (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ATG induction plus TAC, mycophenolate mofetil (MMF) and steroids (Group B)
Number of subjects: 30
Study: 26237777

Group type: EXPERIMENTAL
Intervention: Nap group
Number of subjects: 28

Group type: COMPARATOR
Intervention: Wake group
Number of subjects: 28
Study: 24811758

Group type: EXPERIMENTAL
Intervention: Sigue la Huella intervention
Number of subjects: 682

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 682
Study: 21289590

Group type: COMPARATOR
Intervention: Private physiotherapy (private PT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Public physiotherapy (public PT)
Number of subjects: 160
Study: 19605408

Group type: EXPERIMENTAL
Intervention: McGrath laryngoscope
Number of subjects: 120

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both laryngoscopes
Number of subjects: 120
Study: 17445098

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNTA) at doses of 110 to 260 U per treatment cycle
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: BoNTA
Number of subjects: 369
Study: 15199622

Group type: EXPERIMENTAL
Intervention: Taizhi'an Capsule (TZA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Pravastatin (PVT)
Number of subjects: 78